Cargando…
Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction
Background and purpose: pericoronary fat over-inflammation might lead to the development and destabilization of coronary plaque in patients with pre-diabetes (PDM). Notably, pericoronary fat could over-express the sodium-glucose cotransporter 2 (SGLT2) and leptin, along with decreased sirtuin 6 (SIR...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389537/ https://www.ncbi.nlm.nih.gov/pubmed/34440108 http://dx.doi.org/10.3390/biomedicines9080904 |
_version_ | 1783742881428668416 |
---|---|
author | Sardu, Celestino D’Onofrio, Nunzia Torella, Michele Portoghese, Michele Mureddu, Simone Loreni, Francesco Ferraraccio, Franca Panarese, Iacopo Trotta, Maria Consiglia Gatta, Gianluca Galdiero, Marilena Sasso, Ferdinando Carlo D’Amico, Michele De Feo, Marisa Balestrieri, Maria Luisa Paolisso, Giuseppe Marfella, Raffaele |
author_facet | Sardu, Celestino D’Onofrio, Nunzia Torella, Michele Portoghese, Michele Mureddu, Simone Loreni, Francesco Ferraraccio, Franca Panarese, Iacopo Trotta, Maria Consiglia Gatta, Gianluca Galdiero, Marilena Sasso, Ferdinando Carlo D’Amico, Michele De Feo, Marisa Balestrieri, Maria Luisa Paolisso, Giuseppe Marfella, Raffaele |
author_sort | Sardu, Celestino |
collection | PubMed |
description | Background and purpose: pericoronary fat over-inflammation might lead to the development and destabilization of coronary plaque in patients with pre-diabetes (PDM). Notably, pericoronary fat could over-express the sodium-glucose cotransporter 2 (SGLT2) and leptin, along with decreased sirtuin 6 (SIRT6) expression in PDM vs. normoglycemic (NG) patients undergoing coronary artery bypass grafting (CABG) for acute myocardial infarction (AMI). However, in the current study, we evaluated inflammatory markers, SGLT2, SIRT6, and leptin levels in pericoronary fat and, subsequently, 12-month prognosis comparing PDM to NG subjected to CABG for AMI. In addition, we evaluated in PDM patients the effects of metformin therapy on SIRT6 expression, leptin, and SGLT2 levels, and assessed its beneficial effect on nitrotyrosine and inflammatory cytokine levels. Methods: we studied AMI patients referred for CABG, divided into PDM and NG-patients. PDM patients were divided into never-metformin users and metformin users. Finally, we evaluated major adverse cardiac events (MACE) at a 12-month follow-up. Results: the MACE was 9.1% in all PDM and 3% in NG patients (p < 0.05). Metformin users presented a significantly lower MACE rate in PDM than never-metformin users (p < 0.05). PDM showed higher inflammatory cytokines, 3-nitrotyrosine levels, SGLT2, and leptin content, and decreased SIRT6 protein levels in pericoronary fat compared to NG-patients (p < 0.05). PDM never-metformin-users showed higher SGLT2 and leptin levels in pericoronary fat than current-metformin-users (p < 0.05). Conclusions: metformin therapy might ameliorate cardiovascular outcomes by reducing inflammatory parameters, SGLT2, and leptin levels, and finally improving SIRT6 levels in AMI-PDM patients treated with CABG. |
format | Online Article Text |
id | pubmed-8389537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83895372021-08-27 Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction Sardu, Celestino D’Onofrio, Nunzia Torella, Michele Portoghese, Michele Mureddu, Simone Loreni, Francesco Ferraraccio, Franca Panarese, Iacopo Trotta, Maria Consiglia Gatta, Gianluca Galdiero, Marilena Sasso, Ferdinando Carlo D’Amico, Michele De Feo, Marisa Balestrieri, Maria Luisa Paolisso, Giuseppe Marfella, Raffaele Biomedicines Article Background and purpose: pericoronary fat over-inflammation might lead to the development and destabilization of coronary plaque in patients with pre-diabetes (PDM). Notably, pericoronary fat could over-express the sodium-glucose cotransporter 2 (SGLT2) and leptin, along with decreased sirtuin 6 (SIRT6) expression in PDM vs. normoglycemic (NG) patients undergoing coronary artery bypass grafting (CABG) for acute myocardial infarction (AMI). However, in the current study, we evaluated inflammatory markers, SGLT2, SIRT6, and leptin levels in pericoronary fat and, subsequently, 12-month prognosis comparing PDM to NG subjected to CABG for AMI. In addition, we evaluated in PDM patients the effects of metformin therapy on SIRT6 expression, leptin, and SGLT2 levels, and assessed its beneficial effect on nitrotyrosine and inflammatory cytokine levels. Methods: we studied AMI patients referred for CABG, divided into PDM and NG-patients. PDM patients were divided into never-metformin users and metformin users. Finally, we evaluated major adverse cardiac events (MACE) at a 12-month follow-up. Results: the MACE was 9.1% in all PDM and 3% in NG patients (p < 0.05). Metformin users presented a significantly lower MACE rate in PDM than never-metformin users (p < 0.05). PDM showed higher inflammatory cytokines, 3-nitrotyrosine levels, SGLT2, and leptin content, and decreased SIRT6 protein levels in pericoronary fat compared to NG-patients (p < 0.05). PDM never-metformin-users showed higher SGLT2 and leptin levels in pericoronary fat than current-metformin-users (p < 0.05). Conclusions: metformin therapy might ameliorate cardiovascular outcomes by reducing inflammatory parameters, SGLT2, and leptin levels, and finally improving SIRT6 levels in AMI-PDM patients treated with CABG. MDPI 2021-07-28 /pmc/articles/PMC8389537/ /pubmed/34440108 http://dx.doi.org/10.3390/biomedicines9080904 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sardu, Celestino D’Onofrio, Nunzia Torella, Michele Portoghese, Michele Mureddu, Simone Loreni, Francesco Ferraraccio, Franca Panarese, Iacopo Trotta, Maria Consiglia Gatta, Gianluca Galdiero, Marilena Sasso, Ferdinando Carlo D’Amico, Michele De Feo, Marisa Balestrieri, Maria Luisa Paolisso, Giuseppe Marfella, Raffaele Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction |
title | Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction |
title_full | Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction |
title_fullStr | Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction |
title_full_unstemmed | Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction |
title_short | Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction |
title_sort | metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389537/ https://www.ncbi.nlm.nih.gov/pubmed/34440108 http://dx.doi.org/10.3390/biomedicines9080904 |
work_keys_str_mv | AT sarducelestino metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT donofrionunzia metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT torellamichele metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT portoghesemichele metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT mureddusimone metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT lorenifrancesco metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT ferraracciofranca metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT panareseiacopo metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT trottamariaconsiglia metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT gattagianluca metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT galdieromarilena metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT sassoferdinandocarlo metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT damicomichele metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT defeomarisa metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT balestrierimarialuisa metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT paolissogiuseppe metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction AT marfellaraffaele metformintherapyeffectsontheexpressionofsodiumglucosecotransporter2leptinandsirt6levelsinpericoronaryfatexcisedfromprediabeticpatientswithacutemyocardialinfarction |